Rigel Pharmaceuticals Inc. (New) (RIGL)
Last updated: 2026-10-21 03:23:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Rigel Pharmaceuticals Inc. (New) (RIGL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $48.07, with a market capitalization of $858.71M and a P/E ratio of 2.71. Over the past 52 weeks, its price has ranged from $24.95 to $52.24. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$858.71M | |
$46.73 | |
$310.00 | |
$6.40 | |
$46.72 | |
237.89K | |
271.56K | |
2.71 | |
$52.24 | |
$24.95 | |
-- | |
-- |
Rigel Pharmaceuticals Inc. (New) (RIGL) Latest Closing Stock Price
Rigel Pharmaceuticals Inc. (New) (RIGL) last closed at $46.72 as of 2026-10-21 00:01:00, unchanged from the previous close of $46.72.
During the latest regular trading session, RIGL traded between $6.40 and $310.00, with a volume of 237.89K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Rigel Pharmaceuticals Inc. (New) (RIGL) 7-Day Stock Price Change
Over the past seven days, Rigel Pharmaceuticals Inc. (New) (RIGL) moved from $49.08 to $48.07, representing a decline of 2.07% ($1.02).
The stock traded between $45.48 and $50.49 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 194.81 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
RIGL 52-Week Price Position
Position in Range: 84.7%
RIGL is currently trading at $48.07, placing it 84.7% of the way from its 52-week low of $24.95 to its 52-week high of $52.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Rigel Pharmaceuticals Inc. (New) (RIGL)?
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
Rigel Pharmaceuticals Inc. (New) Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 174 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Rigel Pharmaceuticals Inc. (New) (RIGL) Stock on MEXC
Eligible investors can buy real shares of Rigel Pharmaceuticals Inc. (New) (RIGL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Rigel Pharmaceuticals Inc. (New) (RIGL) stock price today?
2.Is RIGL stock going up or down today?
3.What is RIGL pre-market price?
4.What is RIGL after-hours price?
5.Is RIGL stock trading now?
6.Where does RIGL sit relative to its 52-week high and low?
7.What sector is Rigel Pharmaceuticals Inc. (New) in?
8.What is Rigel Pharmaceuticals Inc. (New)'s market capitalization and where is it listed?
9.How is RIGL valued in terms of P/E ratio and EPS?
10.Does Rigel Pharmaceuticals Inc. (New) pay a dividend?
Explore More US Stocks
Search Stocks
RIGL Stock Calculator
Estimate the value between RIGL shares and USD.
RIGL Shares to USD
1.00 RIGL shares = 48.065 USD
Calculations are estimates based on the latest available price and are for reference only.


